<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-9933</journal-id>
<journal-title><![CDATA[Revista Información Científica]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. inf. cient.]]></abbrev-journal-title>
<issn>1028-9933</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas Guantánamo]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-99332019000100044</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Efectividad del sildenafil en la disfunción sexual eréctil en pacientes con cáncer de próstata]]></article-title>
<article-title xml:lang="en"><![CDATA[Effectiveness of sildenafil in erectile sexual dysfunction in patients with prostate cancer]]></article-title>
<article-title xml:lang="pt"><![CDATA[Eficácia do sildenafil na disfunção sexual erétil em pacientes com câncer de próstata]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ávila Naún]]></surname>
<given-names><![CDATA[Vilma]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez Figueredo]]></surname>
<given-names><![CDATA[Jennifer]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez Chávez]]></surname>
<given-names><![CDATA[Rodolfo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Viñals]]></surname>
<given-names><![CDATA[Terianne]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital General Docente &#8220;Dr. Agostinho Neto&#8221;  ]]></institution>
<addr-line><![CDATA[ Guantánamo]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Facultad de Ciencias Médicas  ]]></institution>
<addr-line><![CDATA[ Guantánamo]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2019</year>
</pub-date>
<volume>98</volume>
<numero>1</numero>
<fpage>44</fpage>
<lpage>52</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-99332019000100044&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-99332019000100044&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-99332019000100044&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  el cáncer de próstata es la primera causa de muerte por cáncer en los hombres cubanos y afecta la calidad de su vida sexual.  Objetivo:  caracterizar los resultados del uso del sildenafil para el manejo de la disfunción sexual eréctil en pacientes con cáncer de próstata tratados con hormonas o radioterapia.  Método:  se realizó un estudio observacional, ambispectivo y transversal, en el Servicio de Urología del Hospital &#8220;Dr Agostinho Neto&#8221; de Guantánamo durante el periodo 2014-2018, que se aprobó por el comité de ética médica. El universo de estudio se conformó por 70 pacientes con diagnóstico de cáncer de próstata, tratados con hormonas o radioterapia, y que presentaron disfunción eréctil. En cada paciente se estudió la edad, tratamiento que se aplicó para el cáncer, tiempo de aparición de la disfunción luego de este, y la respuesta de la función eréctil del pene al uso de sildenafil.  Resultados:  el 37,2 % de los pacientes tenían entre 70 y 79 años de edad y el 79,1 % se trató con hormonas; la mayor proporción presentó disfunción eréctil de 1 a 2 años después del tratamiento (48,8 %); el 81,4 % respondió adecuadamente al tratamiento con sildenafil, lo que fue independiente del tratamiento del cáncer con hormonas o radioterapia.  Conclusiones:  los pacientes con cáncer de próstata tratados con hormonas y/o radioterapia se benefician de los efectos del sildenafil.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  the prostate cancer is the first cause of death for cancer in the Cuban men and it affects the sexual quality of life.  Objective:  to characterize the results of the use of the sildenafil for the management of the erectile sexual dysfunction in patient with prostate cancer tried with hormones or radiotherapy.  Method:  was an observational, ambispective and traverse study, in the Service of Urology of the Hospital Dr. Agostinho Neto of Guantánamo during the period 2014-2018 that it was approved by the committee of medical ethics. The study universe conformed to for 70 patients with diagnostic of prostate cancer, treaties with hormones and/or radiotherapy, and that they presented erectile dysfunction. In each patient was studied the age, treatment that was applied for the cancer, time of appearance of the dysfunction after this, and the answer of the erectile function of the penis to the sildenafil use.  Results:  The 37.2% of the patients had between 70 and 79 years of age and 79.1% were talked with hormones. The biggest proportion presented erectile dysfunction 1 to 2 years after the treatment (48.8%). The 81.4% responded appropriately to the treatment with sildenafil, what was independent of the treatment of the cancer with hormones or radiotherapy.  Conclusion:  The patients with prostate cancer tried with hormones and/or radiotherapy benefitted with the use of the sildenafil.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução:  em Cuba, o câncer de próstata é a principal causa de morte por câncer em homens.  Objetivo:  sistematizar as bases teóricas essenciais que sustentam a autopreparação do estudante de medicina e do clínico geral para sua participação na prevenção, diagnóstico precoce e manejo do paciente com câncer de próstata.  Método:  na Faculdade de Medicina de Guantánamo, entre setembro e dezembro de 2018; foi realizada uma busca nas bases de dados eletrônicas por meio do mecanismo de metabusca do Google Acadêmico.  Resultados:  elaborou-se uma monografia sobre as atuais considerações sobre o câncer de próstata em nível de estudantes de medicina e clínico geral que continha os seguintes núcleos de conhecimento: definição, fisiopatologia, etiologia, diagnóstico e tratamento.  Conclusões:  A expressão clínica desse tipo de câncer é diversa e ainda não tem biomarcadores precisos para o diagnóstico, o que torna inevitável permitindo que clínicos gerais para contribuir de forma eficaz na prevenção e no diagnóstico clínico precoce em termos de assegurar ao paciente um maior chance de cura e sobrevivência.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[cáncer de próstata]]></kwd>
<kwd lng="es"><![CDATA[disfunción sexual eréctil]]></kwd>
<kwd lng="es"><![CDATA[sildenafil]]></kwd>
<kwd lng="en"><![CDATA[prostate cancer]]></kwd>
<kwd lng="en"><![CDATA[erectile sexual dysfunction]]></kwd>
<kwd lng="en"><![CDATA[sildenafil]]></kwd>
<kwd lng="pt"><![CDATA[câncer de próstata]]></kwd>
<kwd lng="pt"><![CDATA[urologia]]></kwd>
<kwd lng="pt"><![CDATA[câncer]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faria]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Soares]]></surname>
<given-names><![CDATA[MO]]></given-names>
</name>
<name>
<surname><![CDATA[Spackman]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optimising the Diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging]]></article-title>
<source><![CDATA[Eur Urol]]></source>
<year>2018</year>
<volume>73</volume>
<page-range>23-30</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[PLY]]></given-names>
</name>
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización clínica-epidemiológica del cáncer de próstata]]></article-title>
<source><![CDATA[Rev Univ Méd Pinar]]></source>
<year>2013</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>2-13</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>Dirección de Registros Médicos y Estadísticas de Salud</collab>
<source><![CDATA[Anuario estadístico de salud 2018]]></source>
<year>2018</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monroy]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Ríos]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[JMR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad de vida sexual posterior a prostatectomía radical]]></article-title>
<source><![CDATA[Rev Mex Urol]]></source>
<year>2014</year>
<volume>74</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>169-75</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[VMJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolución de la Medicina Nuclear en el diagnóstico y tratamiento de pacientes con cáncer de próstata]]></article-title>
<source><![CDATA[Rev Esp Med Nucl Imagen Mol]]></source>
<year>2018</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>71-2</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Federación Latinoamericana de Sociedades de Sexología y Educación Sexual. Asociación Mundial de Sexología Médica</collab>
<source><![CDATA[Manual Diagnóstico de las enfermedades en Sexología]]></source>
<year>2010</year>
<edition>2ed</edition>
<publisher-loc><![CDATA[Caracas ]]></publisher-loc>
<publisher-name><![CDATA[CIPV]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McCabe]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Sharlip]]></surname>
<given-names><![CDATA[ID]]></given-names>
</name>
<name>
<surname><![CDATA[Lewis]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Atalla]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors for sexual dysfunction among women and men A Consensus Statement from the Fourth International Consultation on Sexual]]></article-title>
<source><![CDATA[Medicine 2015]]></source>
<year>2016</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>153-67</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>American Psychiatric Association</collab>
<source><![CDATA[Desk reference to the Diagnostic criteria from DSM-5tm. Arlington]]></source>
<year>2013</year>
<publisher-loc><![CDATA[VA ]]></publisher-loc>
<publisher-name><![CDATA[American Psychiatric Association]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[CJL]]></given-names>
</name>
<name>
<surname><![CDATA[Lorenzo]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Marzullo]]></surname>
<given-names><![CDATA[ZL]]></given-names>
</name>
<name>
<surname><![CDATA[Loras]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Boronat]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implicaciones de la estratificación del cáncer de próstata localizado]]></article-title>
<source><![CDATA[Actas Urol Esp]]></source>
<year>2018</year>
<volume>42</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>103-13</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanchís]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Barrionuevo]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Bajo]]></surname>
<given-names><![CDATA[CAM]]></given-names>
</name>
<name>
<surname><![CDATA[Pulido]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[PLE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validación del índice de salud prostática en un modelo predictivo de cáncer de próstata]]></article-title>
<source><![CDATA[Actas Urol Esp]]></source>
<year>2018</year>
<volume>42</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>25-32</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Villaronga]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mariluis]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Paganini]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualización de la estadificación del cáncer de próstata]]></article-title>
<source><![CDATA[Rev Argent Radiol]]></source>
<year>2013</year>
<volume>77</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>301-5</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Albersen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mwamukonda]]></surname>
<given-names><![CDATA[KB]]></given-names>
</name>
<name>
<surname><![CDATA[Shindel]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Lue]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation and treatment of erectiledys function]]></article-title>
<source><![CDATA[Med Clin North Am]]></source>
<year>2011</year>
<volume>95</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>201-12</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ceballos]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Villaraga]]></surname>
<given-names><![CDATA[ADJ]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[HJM]]></given-names>
</name>
<name>
<surname><![CDATA[Uribe]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía de disfunción eréctil]]></article-title>
<source><![CDATA[Uro Colomb]]></source>
<year>2015</year>
<volume>24</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>185.e2-185.e22</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Linares Espinón]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Barret]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sivaraman]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[RJI]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Rozet]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento focal del cáncer de próstata localizado]]></article-title>
<source><![CDATA[Arc Esp Urol]]></source>
<year>2016</year>
<volume>69</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>345-52</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosen]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Riley]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Wagner]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The international index of erectile function (IIEF) a multidimensional scale for assessment of erectile dysfunction]]></article-title>
<source><![CDATA[Urology]]></source>
<year>1997</year>
<volume>49</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>822-30</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bella]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Carrier]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bénard]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CUA Practice guidelines for erectile dysfunction]]></article-title>
<source><![CDATA[Can Urol Assoc J]]></source>
<year>2015</year>
<volume>9</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>23-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Márquez]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Luque]]></surname>
<given-names><![CDATA[RLG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Disfunción eréctil en pacientes intervenidos de cáncer de próstata. Revisión sistemática de la literatura médica]]></article-title>
<source><![CDATA[Actas Urol Esp]]></source>
<year>2010</year>
<volume>34</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>677-85</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Katelaris]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Lawrentschuk]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Katelaris]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Moon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cytoreductive surgery for men with metastatic prostate cancer]]></article-title>
<source><![CDATA[Prostate Int]]></source>
<year>2016</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>103-6</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[DZE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento hormonal con zoladex más casodex en pacientes geriátricos con cáncer de próstata]]></article-title>
<source><![CDATA[Medicentro]]></source>
<year>2015</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>59-60</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Comas]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Planas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Celma]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Regis]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Morote]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Métodos para cuantificar la testosterona sérica en pacientes con cáncer de próstata: una revisión sistemática]]></article-title>
<source><![CDATA[Actas Urol Esp]]></source>
<year>2018</year>
<volume>42</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>86-93</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
